Results 191 to 200 of about 17,467 (253)

Synthesising key findings from Indonesia's first civil society-led forum on primary health care: PHC forum, Jakarta, 13-14 November 2023. [PDF]

BMC Proc
Saminarsih DS, Magdalena CC, Febianisari N, Meilissa Y, Hamid SN, Hafizon MI, Jundullah SM, Herlinda O.   +7 more
europepmc   +1 more source

A Method for Optical Quantification of Local Oxygen Limitations in Multiphase Bioreactors

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Spatial oxygen limitation is a major source of physiological stress and metabolic, scale‐dependent heterogeneity in aerobic bioprocesses. In gas‐liquid stirred tank reactors, oxygen availability is governed by hydrodynamics and mass transfer and is therefore inherently non‐uniform.
Ryan Rautenbach, Katharina Zörner, Jonas Barczyk, Marko Hoffmann, Ralf Takors, Michael Schlüter   +5 more
wiley   +1 more source

An international overview of child protection services to protect unborn children from significant harm. [PDF]

J Soc Welf Fam Law
Zijlstra A, Bruning MR, van Nieuwenhuijzen M, de Castro BO.   +3 more
europepmc   +1 more source

Minimizing Off‐Target Effects of CRISPR‐Cas9 With Optimized sgRNA: Evaluation of Efficiency and Specificity in the Tumor Protein 53 (TP53) Region

Biotechnology and Bioengineering, EarlyView.
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) – Cas9‐based genome editing has emerged as a widely used tool across various disciplines, ranging from molecular biology to gene therapy. This revolutionary technology, which enables precise gene editing, represents a significant advancement in biotechnology, opening new frontiers for ...
Ali Mertcan Köse, Monia Ranalli, Drenka Trivanovic, Irina Maslovaric   +3 more
wiley   +1 more source

Expressing intentions is not climate action. [PDF]

Proc Natl Acad Sci U S A
Dablander F, Lange F, Brick C, Aron AR.
europepmc   +1 more source

Glycoengineered Recombinant Alpha1‐Antitrypsin Results in Comparable In Vitro and In Vivo Activities to Human Plasma‐Derived Protein

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Alpha‐1‐antitrypsin (A1AT) is a multifunctional, clinically important, high‐value therapeutic glycoprotein that can be used for the treatment of many diseases, such as A1AT deficiency, diabetes, graft‐versus‐host disease, cystic fibrosis, and various viral infections. Currently, the only U.S. food and drug administration‐approved treatment for
Frances Rocamora, Chen‐Lin Hsieh, Sanne Schoffelen, Johnny Arnsdorf, Eric A. Toth, Abdul S. Yunus, Thomas E. Cleveland IV, Sara Petersen Bjørn, Mina Ying Min Wu, Noel G. McElvaney, Bjørn Gunnar Rude Voldborg, Thomas R. Fuerst, Nathan E. Lewis   +12 more
wiley   +1 more source

Lost and found: trends in litigation and compensation related to retained surgical foreign bodies. [PDF]

Front Med (Lausanne)
Grassi S, Focardi M, Santori F, Guerini M, Ferri E, Ferretti G, Bianchi I, Autieri F, Pinchi V.   +8 more
europepmc   +1 more source

Statistic tells: the regulatory pendulum of permit trajectories in China's genetic governance (2021-2024). [PDF]

Front Genet
Song L, Liu Z, Meng F.
europepmc   +1 more source

Justice system experiences and health risks among Medicaid and uninsured populations receiving treatment for substance use disorder. [PDF]

J Subst Use Addict Treat
O'Neil MM, Pryor J, Johnson RA, Kim M, Nguyen C, Pinals DA.   +5 more
europepmc   +1 more source